Evidence map›Paper›PMID 20655268›Full record

ArticleTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine2010

Erythrocyte adducin: a structural regulator of the red blood cell membrane.

T Franco, P S Low

Abstract read
In one paragraph

Article in Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. mBio · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. iScience · 2023
    Article
  7. Article
  8. Article
  9. Yeast as a Model to Find New Drugs and Drug Targets forInternational journal of molecular sciences · 2022
    Review
  10. Lab on a chip · 2021
    Article
  11. Article
  12. Deformability of Stored Red Blood Cells.Frontiers in physiology · 2021
    Review
  13. Erythroid glucose transport in health and disease.Pflugers Archiv : European journal of physiology · 2020
    Review
  14. Human erythrocytes: cytoskeleton and its origin.Cellular and molecular life sciences : CMLS · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

T FrancoDepartment of chemistry, Purdue University, 560, Oval Drive, West Lafayette, IN 47907-2084, USA.
P S Low
Purdue University West Lafayette · US

Funding

Studies of Erythrocyte Membrane StructureR01GM024417 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI LOW, PHILIP STEWART · 1985 to 2020
$5.4M
NIGMS NIH HHS R01 GM024417
6 · The paper itself

Abstract

Adducin is an alpha, beta heterotetramer that performs multiple important functions in the human erythrocyte membrane. First, adducin forms a bridge that connects the spectrin-actin junctional complex to band 3, the major membrane-spanning protein in the bilayer. Rupture of this bridge leads to membrane instability and spontaneous fragmentation. Second, adducin caps the fast growing (barbed) end of actin filaments, preventing the tetradecameric protofilaments from elongating into macroscopic F-actin microfilaments. Third, adducin stabilizes the association between actin and spectrin, assuring that the junctional complex remains intact during the mechanical distortions experienced by the circulating cell. And finally, adducin responds to stimuli that may be important in regulating the global properties of the cell, possibly including cation transport, cell morphology and membrane deformability. The text below summarizes the structural properties of adducin, its multiple functions in erythrocytes, and the consequences of engineered deletions of each of adducin subunits in transgenic mice.

Indexed as

ActinsAdducinsAnimalsAnion Exchange Protein 1, ErythrocyteBlood ProteinsCalmodulin-Binding ProteinsErythrocyte DeformabilityErythrocyte MembraneErythrocytesGlucose Transport Proteins, FacilitativeHomeostasisHumansLipid BilayersMembrane ProteinsMiceMice, TransgenicActinsAdducinsAnion Exchange Protein 1, ErythrocyteBlood ProteinsCalmodulin-Binding ProteinsGlucose Transport Proteins, FacilitativeLipid BilayersMembrane ProteinsSpectrinSTOM protein, humanStom protein, mouse

Identifiers

PMID20655268
PMCPMC3385930
OpenAlexW1983916024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.